CN102178814B - 一种治疗滴虫性阴道炎的中药组合物及其制备方法 - Google Patents
一种治疗滴虫性阴道炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN102178814B CN102178814B CN2011100918471A CN201110091847A CN102178814B CN 102178814 B CN102178814 B CN 102178814B CN 2011100918471 A CN2011100918471 A CN 2011100918471A CN 201110091847 A CN201110091847 A CN 201110091847A CN 102178814 B CN102178814 B CN 102178814B
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- radix
- medicine
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 208000007074 Trichomonas Vaginitis Diseases 0.000 title abstract description 5
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 title abstract description 5
- 238000002360 preparation method Methods 0.000 title description 21
- 239000003814 drug Substances 0.000 claims abstract description 166
- 229940079593 drug Drugs 0.000 claims abstract description 48
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 13
- 244000286838 Eclipta prostrata Species 0.000 claims abstract description 7
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims abstract description 7
- 229940097275 indigo Drugs 0.000 claims abstract description 7
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000011282 treatment Methods 0.000 claims description 41
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 claims description 37
- 239000000843 powder Substances 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 28
- 238000010438 heat treatment Methods 0.000 claims description 22
- 235000009508 confectionery Nutrition 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 17
- 239000000829 suppository Substances 0.000 claims description 16
- 210000000582 semen Anatomy 0.000 claims description 15
- 241000545442 Radix Species 0.000 claims description 14
- 239000006187 pill Substances 0.000 claims description 10
- 239000000758 substrate Substances 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 8
- 239000002552 dosage form Substances 0.000 claims description 7
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 claims description 6
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 6
- 235000005903 Dioscorea Nutrition 0.000 claims description 6
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 6
- 241000219295 Portulaca Species 0.000 claims description 6
- 241000501098 Sargentodoxa Species 0.000 claims description 6
- 241000207929 Scutellaria Species 0.000 claims description 6
- 235000004879 dioscorea Nutrition 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 235000012907 honey Nutrition 0.000 claims description 6
- 238000007670 refining Methods 0.000 claims description 5
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 238000002844 melting Methods 0.000 claims description 4
- 230000008018 melting Effects 0.000 claims description 4
- 235000011837 pasties Nutrition 0.000 claims description 4
- 229960000502 poloxamer Drugs 0.000 claims description 4
- 229920001983 poloxamer Polymers 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000007493 shaping process Methods 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 2
- 241000234273 Dioscorea Species 0.000 claims 3
- 208000003251 Pruritus Diseases 0.000 abstract description 29
- 239000009636 Huang Qi Substances 0.000 abstract description 12
- 230000008901 benefit Effects 0.000 abstract description 9
- 230000007803 itching Effects 0.000 abstract description 7
- 235000013399 edible fruits Nutrition 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 235000011034 Rubus glaucus Nutrition 0.000 abstract description 2
- 244000235659 Rubus idaeus Species 0.000 abstract description 2
- 235000009122 Rubus idaeus Nutrition 0.000 abstract description 2
- 238000001647 drug administration Methods 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000007650 Aralia spinosa Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000212948 Cnidium Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 240000007371 Cuscuta campestris Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 241000972673 Phellodendron amurense Species 0.000 abstract 1
- 244000234609 Portulaca oleracea Species 0.000 abstract 1
- 235000001855 Portulaca oleracea Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 244000007853 Sarothamnus scoparius Species 0.000 abstract 1
- 241000949456 Zanthoxylum Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 70
- 210000004369 blood Anatomy 0.000 description 69
- 210000003734 kidney Anatomy 0.000 description 39
- 230000000694 effects Effects 0.000 description 35
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 26
- 210000000952 spleen Anatomy 0.000 description 26
- 201000010099 disease Diseases 0.000 description 25
- 210000004185 liver Anatomy 0.000 description 23
- 208000002193 Pain Diseases 0.000 description 21
- 238000012360 testing method Methods 0.000 description 20
- 230000007812 deficiency Effects 0.000 description 19
- 230000006870 function Effects 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 208000024891 symptom Diseases 0.000 description 17
- 210000001215 vagina Anatomy 0.000 description 17
- 210000002784 stomach Anatomy 0.000 description 16
- 231100000614 poison Toxicity 0.000 description 14
- 230000001717 pathogenic effect Effects 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 12
- 208000001848 dysentery Diseases 0.000 description 12
- 230000002147 killing effect Effects 0.000 description 12
- 239000006210 lotion Substances 0.000 description 12
- 230000027939 micturition Effects 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 11
- 210000004209 hair Anatomy 0.000 description 11
- 206010007247 Carbuncle Diseases 0.000 description 10
- 241000700199 Cavia porcellus Species 0.000 description 10
- 210000003756 cervix mucus Anatomy 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- 230000005906 menstruation Effects 0.000 description 10
- 244000045947 parasite Species 0.000 description 10
- 208000006820 Arthralgia Diseases 0.000 description 9
- 206010061218 Inflammation Diseases 0.000 description 9
- 210000001624 hip Anatomy 0.000 description 9
- 230000004054 inflammatory process Effects 0.000 description 9
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 230000036461 convulsion Effects 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 210000004877 mucosa Anatomy 0.000 description 8
- 244000052769 pathogen Species 0.000 description 8
- 229940023488 pill Drugs 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- 206010010904 Convulsion Diseases 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 241000588653 Neisseria Species 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 7
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 7
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- 208000033809 Suppuration Diseases 0.000 description 7
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 7
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 7
- 229960003321 baicalin Drugs 0.000 description 7
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 230000028327 secretion Effects 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 210000001835 viscera Anatomy 0.000 description 7
- 241000222122 Candida albicans Species 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- 208000008350 Pruritus Vulvae Diseases 0.000 description 6
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 208000025747 Rheumatic disease Diseases 0.000 description 6
- 206010046914 Vaginal infection Diseases 0.000 description 6
- 229940095731 candida albicans Drugs 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 210000002683 foot Anatomy 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 230000003014 reinforcing effect Effects 0.000 description 6
- 230000000552 rheumatic effect Effects 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 5
- 208000005171 Dysmenorrhea Diseases 0.000 description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 241000201295 Euphrasia Species 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 5
- 241000192041 Micrococcus Species 0.000 description 5
- 241000588769 Proteus <enterobacteria> Species 0.000 description 5
- 208000009205 Tinnitus Diseases 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000003628 erosive effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000001605 fetal effect Effects 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 230000001568 sexual effect Effects 0.000 description 5
- 231100000886 tinnitus Toxicity 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 4
- 229920002527 Glycogen Polymers 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000001139 anti-pruritic effect Effects 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 210000003679 cervix uteri Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000001780 epistaxis Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 229940096919 glycogen Drugs 0.000 description 4
- 208000035861 hematochezia Diseases 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 201000001881 impotence Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 238000000386 microscopy Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 210000003905 vulva Anatomy 0.000 description 4
- 238000003809 water extraction Methods 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- 208000001387 Causalgia Diseases 0.000 description 3
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 3
- 244000281702 Dioscorea villosa Species 0.000 description 3
- 208000000616 Hemoptysis Diseases 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 206010033799 Paralysis Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 208000005448 Trichomonas Infections Diseases 0.000 description 3
- 206010044620 Trichomoniasis Diseases 0.000 description 3
- 201000008100 Vaginitis Diseases 0.000 description 3
- 208000012886 Vertigo Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000002605 anti-dotal effect Effects 0.000 description 3
- 239000003716 antitrichomonal agent Substances 0.000 description 3
- 239000013040 bath agent Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 208000034158 bleeding Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000001076 estrogenic effect Effects 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 231100000682 maximum tolerated dose Toxicity 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000035943 smell Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 230000009182 swimming Effects 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 231100000820 toxicity test Toxicity 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 231100000889 vertigo Toxicity 0.000 description 3
- XWBADQOPXPRKBX-FMIVXFBMSA-N 1-n,1-n-diethyl-4-n-[6-methoxy-2-[(e)-2-(4-nitrophenyl)ethenyl]quinolin-4-yl]pentane-1,4-diamine Chemical compound N=1C2=CC=C(OC)C=C2C(NC(C)CCCN(CC)CC)=CC=1\C=C\C1=CC=C([N+]([O-])=O)C=C1 XWBADQOPXPRKBX-FMIVXFBMSA-N 0.000 description 2
- OIGWAXDAPKFNCQ-UHFFFAOYSA-N 4-isopropylbenzyl alcohol Chemical compound CC(C)C1=CC=C(CO)C=C1 OIGWAXDAPKFNCQ-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010033078 Otitis media Diseases 0.000 description 2
- 241000517307 Pediculus humanus Species 0.000 description 2
- 206010034568 Peripheral coldness Diseases 0.000 description 2
- 206010037714 Quadriplegia Diseases 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 241000607626 Vibrio cholerae Species 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229960003405 ciprofloxacin Drugs 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000002951 depilatory effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 206010013023 diphtheria Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 206010014881 enterobiasis Diseases 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000008921 jie er yin Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 229960000282 metronidazole Drugs 0.000 description 2
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000003860 topical agent Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000003812 trophozoite Anatomy 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 210000002229 urogenital system Anatomy 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 238000011121 vaginal smear Methods 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000007415 Anhedonia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000007163 Dermatomycoses Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 238000006424 Flood reaction Methods 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010027145 Melanocytic naevus Diseases 0.000 description 1
- 208000027530 Meniere disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000007256 Nevus Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000005267 amalgamation Methods 0.000 description 1
- 229940071110 amino-cerv Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000009989 contractile response Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 235000021551 crystal sugar Nutrition 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 201000003929 dermatomycosis Diseases 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940059082 douche Drugs 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000003450 growing effect Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000011833 infective vaginitis Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000244 kidney pelvis Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 230000036445 liquid secretion Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940100691 oral capsule Drugs 0.000 description 1
- 229940042126 oral powder Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- -1 sublimed preparation Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗滴虫性阴道炎的中药组合物,其中:内服药物为:制首乌10~20份,当归10~20份,白术10~20份,山药10~20份,黄芪10~20份,大枣10~20份,菟丝子10~20份,鸡血藤10~20份,桑葚10~20份,泽泻10~20份,旱莲草10~20份,覆盆子10~20份,熟地黄10~20份,黄芩10~20份,丹皮10~20份;外用药物为:黄柏10~30份,苦参10~30份,蛇床子10~30份,青黛10~30份,艾叶10~30份,百部10~30份,红藤10~30份,鸡血藤10~30份,花椒10~30份,乌梅10~30份,地肤子10~30份,冰片10~30份,马齿苋10~30份。本发明具有止痒迅速,消炎抗菌性强,并且给药方便,药剂易于制造,成本低廉等优点。
Description
技术领域
本发明涉及含有来源于植物、动物或矿物组份的医用配制品,特别涉及一种治疗滴虫性阴道炎的中药组合物及其制备方法。
背景技术
阴道炎是一种妇科常见病、多发病,经常困扰着许多妇女,严重者可影响病人的学习、工作和妇女的一生。临床主要表现霉菌性阴道炎,滴虫性阴道炎,细菌性阴道炎。此病属于中医带下、阴痒范畴。主要临床表现为带下量多、色、质发生异常变化。滴虫阴道炎是常见的阴道炎,由阴道毛滴虫所引起。临床上以白带增多、质稀有泡沫、秽臭,阴道瘙痒为主要表现。发病是由于感染的阴道毛滴虫消耗了阴道内的糖原,破坏了阴道的自净防御机能,继发细菌感染所致。
滴虫呈梨形,后端尖,约为多核白细胞的2~3倍大小。虫体顶端有鞭毛4根,体部有波动膜,后端有轴柱凸出。活的滴虫透明无色,呈水滴状,诸鞭毛随波动膜的波动而摆动,滴虫的生活史简单,只有滋养体而无包囊期,滋养体生活力较强,能在3~5℃生存2日;在46℃时生存20~60分钟;在半干燥环境中约生存10小时;在普通肥皂水中也能生存45~120分钟。在Ph5以下或7.5以上的环境中则不生长,滴虫阴道炎患者的阴道PH值一般为5.1~5.4。隐藏在腺体及阴道皱襞中的滴虫于月经前后,常得以繁殖,引起炎症的发作。它能消耗或吞噬阴道上皮细胞内的糖原,阻碍乳酸生成。滴虫不仅寄生于阴道。还常侵入尿道或尿道旁腺,甚至膀胱、肾盂以及男性的包皮褶、尿道或前列腺中。滴虫性阴道炎是感染了阴道毛滴虫后引起的一种阴道炎症。是最常见的阴道炎症之一。直接传染:经性交传播;间接传染:经公共浴池、浴盆、浴中、游泳池、厕所、衣物、器械及敷料等途径任何人都有可能被感染滴虫性阴道炎,而那些阴道酸碱度有改变或免疫力低下的人群则更易于感染。感染滴虫后患者能自愈者极少, 即使治愈,还可以下次再感染。滴虫病的传染源就是那些带虫者和被污染的物体。白带增多及外阴瘙痒滴虫阴道炎的主要症状是稀薄的泡沫状白带增多及外阴瘙痒,若有其他细菌混合感染则排出物呈脓性,可有臭味,瘙痒部位主要为阴道口及外阴,间或有灼热、疼痛、性交痛等。若尿道口有感染,可有尿频、尿痛,有时可见血尿。检查时可见阴道粘膜充血,严重者有散在的出血斑点,后穹窿有多量白带,呈灰黄色、黄白色稀薄液体或为黄绿色脓性分泌物,常呈泡沫状。带虫者阴道粘膜可无异常发现。少数患者阴道内有滴虫存在而无炎症反应,称为带虫者。有人认为滴虫单独存在时不能引起炎症,因其消耗阴道上皮细胞内糖原,改变了阴道酸碱度,破坏了防御机制,促进继发性的细菌感染,故常在月经期前后、妊娠期或产后等阴道Ph改变时,引起炎症发作。
滴虫性阴道炎传播途径有直接传播即性生活传播和间接传播两种。在国外,阴道滴虫病主要是通过性生活传播,因此将它归属于性传播疾病。在我国则传播方式有所不同。由于我国人口多,公共卫生设施较发达国家相对落后,因此,公共场所的传播也成为重要的传播途径。例如,公共浴池的坐椅或公共厕所的坐便器被带虫者的分泌物污染,那么后来者如果直接坐在坐椅或坐便器上就有可能被传染。公共浴池的盆塘,夏天里密度很大又消毒不严的游泳池,借穿他人内裤,租用泳衣等,都可能造成滴虫的传播。另外,家庭成员间互用洗浴盆、医源性交叉感染,也是导致滴虫间接传播的原因。男性滴虫病患者仅有不到20%有症状,其他人都是症状带虫者。如果仅妻子治疗,而丈夫不治,性生活又无保护,妻子即使治愈,也会通过性生活被丈夫再次传染。如此周而复始,双方的滴虫病都顽固难愈。因此,对患滴虫性阴道炎的妇女必须要求夫妻双方同时治疗。西药治疗药物很多,有抗菌药物如甲硝唑、环丙沙星等,微生态治疗制剂如乳酸杆菌、地衣芽孢杆菌。抗生素治疗妇科的各种生殖泌尿系统炎症及痛经带下等效果很不理想,用西药治疗此类妇科病,不但疗效差、易复发,而且副作用大,又没有特效的中成药。临床以中医师随病证外方作汤剂口服,以及一些中药洗剂,但治疗效果均不甚理想,存在着可诱发耐药性、复发率高、用药不便、制剂困难等不足。而目前已经公开地用于治疗阴道炎的药物,如:“恩威牌”洁尔阴洗液,仍然不能达到理想的抗炎、止痒效果。 临床上虽然还有一些治疗阴道炎的外用药,但疗效均不太理想。许多患者迫切希望能有一种使用方便而效果好的外用药物,用于治疗各种类型的阴道炎,针对这种情况发明人发明了这种中药组合,标本兼治,以内养外,达到理想的治疗效果,且无毒副作用,使用方便,治愈时间短,治愈后不易复发。
发明内容
本发明所要解决的技术问题在于,本病西药有抗菌药物如甲硝唑、环丙沙星等,微生态治疗制剂如乳酸杆菌、地衣芽孢杆菌。但抗生素治疗妇科的各种生殖泌尿系统炎症及痛经带下等效果很不理想,用西药治疗此类妇科病,不但疗效差、易复发,而且副作用大,没有特效的中成药。临床以中医师随病证外方作汤剂口服,以及一些中药洗剂,但治疗效果均不甚理想,存在着可诱发耐药性、复发率高、用药不便、制剂困难等不足。临床迫切需要提供了一种见效快、副作用小、抑菌性强,止痒杀虫效果迅速的的药物,能有效解除患者的痛苦。
为解决上述技术问题,本发明提供了一种治疗滴虫性阴道炎的中药组合物,由内服药物和外用药物组成,所述内服药物中各种原料药的重量份数比为:制首乌10~20份,当归10~20份,白术10~20份,山药10~20份,黄芪10~20份,大枣10~20份,菟丝子10~20份,鸡血藤10~20份,桑葚10~20份,泽泻10~20份,旱莲草10~20份,覆盆子10~20份,熟地黄10~20份,黄芩10~20份,丹皮10~20份;
所述外用药物中,各种原料药的重量份数比为:黄柏10~30份,苦参10~30份,蛇床子10~30份,青黛10~30份,艾叶10~30份,百部10~30份,红藤10~30份,鸡血藤10~30份,花椒10~30份,乌梅10~30份,地肤子10~30份,冰片10~30份,马齿苋10~30份。
所述治疗滴虫性阴道炎的中药组合物,内服药物中各种原料药的重量份数比还可以为:制首乌10~20份,当归10~20份,白术10~20份,山药10~20份,黄芪10~20份,大枣10~20份,菟丝子10~20份,鸡血藤10~15份,桑葚10~15份,泽泻10~15份,旱莲草10~15份,覆盆子10~15份,熟地黄10~15份,黄芩10~15份,百部10~15份;
所述外用药物中,各种原料药的重量份数比还可以为:黄柏10~30份,苦参10~30份,蛇床子10~30份,青黛10~30份,艾叶10~30份,百部10~15份,红藤10~15份,鸡血藤10~15份,花椒10~15份,乌梅10~15份,地肤子10~15份,冰片10~15份,马齿苋10~15份。
所述治疗滴虫性阴道炎的中药组合物,内服药物中各种原料药的重量份数比也可以为:制首乌10~15份,当归10~15份,白术10~15份,山药10~15份,黄芪10~15份,大枣10~15份,菟丝子10~15份,鸡血藤10~20份,桑葚10~20份,泽泻10~20份,旱莲草10~20份,覆盆子10~20份,熟地黄10~20份,黄芩10~20份,百部10~20份;
所述外用药物中,各种原料药的重量份数比也可以为:黄柏10~15份,苦参10~15份,蛇床子10~15份,青黛10~15份,艾叶10~15份,百部10~30份,红藤10~30份,鸡血藤10~30份,花椒10~30份,乌梅10~30份,地肤子10~30份,冰片10~30份,马齿苋10~30份。
为解决上述技术问题,本发明提供一种治疗滴虫性阴道炎的中药制剂的制备方法,所述内服药物的剂型为蜜炼丸剂的制备方法包括:先将所述内服原料药粉碎成粗粉,再进一步粉碎,过100目~120目筛,使能通过筛的细粉量为30%,收集通过筛的细粉得细粉a;再将不能通过120目筛的粗粉投入多功能提取罐提取两次,第一次加5-10倍量水煎煮1-2小时,第二次加4-8倍量水煎煮1-2小时,合并两次煎液,过滤得滤液;加热浓缩至糊状,放入烘箱80℃烘干后冷却,研磨成细粉b,将a与b混合后调入蜂蜜制成蜜炼丸剂。
为解决上述技术问题,本发明提供一种治疗滴虫性阴道炎的中药制剂的制备方法,所述外用药物的剂型为栓剂的制备方法包括:将所述原料药除冰片外,其余加水浸泡30分钟至1小时,加热煮沸30~40分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30~40分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸30~40分钟,过滤;将三次滤液合在一起,加热浓缩至膏状,加入研碎的冰片混在一起;选取基质50℃~60℃加热融化,加入上述得到的药膏冷却定型制成类弹头状栓剂。
所述治疗滴虫性阴道炎的外用药物所述基质优选为:半合成脂肪酸甘油酯、泊洛沙姆、聚乙二醇、羊毛脂中的一种或多种。
为解决上述技术问题,本发明提供一种治疗滴虫性阴道炎的中药制剂的制备方法,所述内服药物或所述外用药物的剂型为散剂,制备方法包括:
a.将所述原料药混合,切碎,浸泡;
b.将浸泡的原料药加水加热回流提取2次;
c.再取上述水提取后的药渣,加乙醇加热回流提取2次;
d.将上述两种提取液合并,减压回收乙醇并消毒制剂。
所述步骤b中将将浸泡好的原料药加重量份数比为5~8倍量水加热回流提取2次,每次1~2小时,将2次提取液合并静置;所述步骤c中,将上述水提取过的药渣加5~8倍量60~70%乙醇加热回流提取2次,每次1~2小时,将2次提取液合并静置。
所述步骤d中将上述两种提取液合并,减压浓缩相对密度为1.35(80℃)的滤液,回收乙醇,将所得滤液调整比重到1.06,减压得浸膏,用Co60灭菌,辐照剂量8k,放入烘箱内干燥成散剂。
为解决上述技术问题,本发明提供一种治疗滴虫性阴道炎的中药组合物,其内服药物剂型优选为:片剂、糖衣片剂、薄膜衣片剂、肠溶衣片剂、胶囊剂、硬胶囊剂、软胶囊剂、口服液、口含剂、颗粒剂、冲剂、蜜丸剂、散剂、丹剂、溶液剂、注射剂、栓剂、硬膏剂、糖浆剂;外用药物剂型优选为:栓剂、散剂、坐浴剂、洗液剂、泡腾片、阴道灌洗剂和喷雾剂;本发明治疗滴虫性阴道炎的中药组合物,外用药剂可以单独使用,作为妇科洗液,预防治疗滴虫性阴道炎的妇科用药。
本发明外用散剂可直接用温水冲泡作为坐浴药液使用,栓剂中所述基质在温度50℃~60℃条件下加热融化,加入所述外用药物的粉剂中成药,水浴搅拌均匀,混合成粘稠的液体,灌注在塑料定型管内,插入棉栓,冷却定型制成子弹头状栓剂;所述粉剂中成药与基质的配比为1∶2~1∶4;所述棉栓为尾部带有棉线的棉栓。
本发明采用药栓和棉栓一体工艺,弥补了普通栓剂的不足,普通栓剂不能有效送达到阴道的深处。由于阴道的自净作用,当有异物存在时,会增加液体分泌,在短时间内将药物排除体外,既降低了疗效,又延长了疗程,增加费用又污染内衣裤。而本发明克服值以难题,制成的栓剂可充分发挥药物疗效,具有安全性好,可行性好的优点,能直达病灶,达到祛病 目的。
与现有技术相比教,本发明具有止痒迅速,消炎抗菌性强,并且给药方便,药剂易于制造,成本低廉等优点。本发明采用不同药性的中药材,进行了科学配伍,能达到理想的治疗效果,且安全,毒副作用小,使用方便,治愈时间短,治愈后不易复发。能创造较好的社会价值及经济利益。
具体实施方式
滴虫性阴道炎多见外阴、阴道瘙痒不堪,甚则痒痛难忍,坐卧不安。本症病因甚多,表现各异,但总括发病机理多与湿热下注有关。现代中医认为,本病发病之由,由于素体脾虚,不能运化水湿;或奢食辛辣肥甘酒类,损伤脾胃,酿湿生热,下注阴部;或劳倦伤脾,脾虚生湿,湿浊蕴遏,久而化热,湿热熏蒸于下;或肝经湿热下注;或感染湿热秽浊,失于卫生,湿浊下注,发为带下。《医宗金鉴·妇科心法要诀》所说“妇人阴痒,多因湿热生虫”即是此意。显然,引发阴道炎的原因应属后者。按照传统中医理论,由内因所致者以内服药调整功能为主,而因外感病虫所致者或辅以外治或以外治为主要手段。由于感染湿邪病虫所致之阴痒、带下者多表现为肝经湿热,因而治疗应以清热除湿、杀虫止痒为原则。本病主要是因湿热蕴结,虫蚀阴中所致湿热之邪有内外之分。如久居湿地等致湿邪外侵,郁而化热,或经期、产后,湿热邪毒乘虚而入,此为外感湿热。若素体脾气虚弱,或肝气郁结,木克脾土,脾失健运,水湿内留,停注下焦,蕴而化热,则为内生湿热。湿热蕴结,韧带不固,则带下增多,色黄。下焦湿热,膀优失约则并发淋证;湿邪浸淫日久成毒,或感染热毒邪气,热盛迫血妄行,或湿毒腐蚀肌肤,则可见带下脓血,或见″阴蚀″、″阴疮″。湿腐生虫,或摄生不慎,虫邪直犯阴器,虫蚀阴中则阴痒,阴中灼痛本病虽病在阴器,但每与肝脾等脏腑有关。多因湿邪为病。显然,引发感染性阴道炎的原因应属后者。按照传统中医理论,由内因所致者以内服药调整功能为主,而因外感病虫所致者或辅以外治或以外治为主要手段。本中药组合中外用采用中药方中蛇床子、地肤子黄柏、苦参、能祛风燥湿,杀虫止痒;鸡血藤,花椒清热解毒,养血活血、促进外阴阴道局部血液循环,修复萎缩粘膜,增强粘膜抗损伤能力,使局部炎症消失,乌梅,百部、枯矾有解毒杀虫杀菌、止痒的作用, 艾叶有补气虚除湿功效,青黛,马齿苋都是外科去腐生肌之良药,冰片清凉止痒,诸药配伍,乘热熏洗外阴,使局部症状缓解最终治愈。
蛇床子性辛、苦,温;有小毒。归肾经。主治温肾壮阳,燥湿,祛风,杀虫。用于阳痿,宫冷,寒湿带下,湿痹腰痛;外治外阴湿疹,妇人阴痒;滴虫性阴道炎,是妇科外用良药。《本草经疏》载:蛇床子,味苦平;《别录》辛甘无毒;今详其气味,当必兼温燥,阳也。故主妇人阴中肿痛,男子阴痿湿痒,除痹气,利关节,恶疮。《别录》温中下气,令妇人子服热,男子阴强,令人有子。盖以舌能除湿,温能散寒,辛能润肾,甘能益脾,故能除妇人男子一切虚寒湿所生病。寒湿既除,则病去,性能益阳,故能已疾,而又有补益也。
黄柏清热燥湿,泻火除蒸,解毒疗疮。用于湿热泻痢,黄疸,带下,热淋,脚气,痿辟,骨蒸劳热,盗汗,遗精,疮疡肿毒,湿疹瘙痒。盐黄柏滋阴降火。用于阴虚火旺,盗汗骨蒸。《中国药典》载黄柏清热燥湿之力,与黄芩、黄连相似,但以除下焦之湿热为佳。
桑葚,甘,淡,平入心、肺经。功效祛风利湿,清热解毒。主治感冒发热,风湿痹痛,痢疾,水肿,白带,吐血,痈肿,外伤出血,毒蛇咬伤,急惊风,破伤风,哮喘,胃痛产后风。.《陆川本草》载:破积,散毒。治跌打损伤,疮痈,是治疗妇科的外科良药。
苦参性苦,寒。归心、肝、胃、大肠、膀胱经清热燥湿,杀虫,利尿。用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风;外治滴虫性阴道炎,常与黄柏结合使用,是治疗阴道炎的外用妇科良药。
青黛具有清热,凉血,解毒的功效,且性甘,平,无毒,入肝、肺、胃经。《纲目》:去热烦,吐血,咯血,斑疮,阴疮,杀恶虫。。清热解毒,凉血,定惊,用于温毒发斑,血热吐衄,胸痛咳血。据《要药分剂》载:除热解毒,兼能凉血。
花椒除各种肉类的腥气;促进唾液分泌,增加食欲;使血管扩张,从而起到降低血压的作用;服花椒水能去除寄生虫;有芳香健胃、温中散寒、除湿止痛、杀虫解毒、止痒解腥的功效。性味辛、温,有小毒,麻.成分果含挥发油(为柠檬烯、枯醇、香叶醇等)、淄醇,不饱和有机酸。药理 抑菌试验:花椒对炭疽杆菌、溶血性链球菌、白喉杆菌、肺炎双球菌、金黄色葡萄球菌、柠檬色及白色葡萄球菌、枯草杆菌等10种革兰氏阳性菌,以及大肠杆菌、宋内氏痢疾杆笛、变形杆菌、伤寒及副伤寒杆菌、绿脓杆菌、霍乱弧菌等肠内致病菌均有明显的抑制作用。1∶4的水浸剂对星形奴卡氏菌亦有抑制作用。
艾叶性温入脾、肝、肾经理气血,逐寒湿;温经,止血,安胎。治心腹冷痛,泄泻转筋,久痢,吐衄,下血,月经不调,崩漏,带下,《纲目》载:温中,逐冷,除湿,还可以杀虫。
鸡血藤性苦、甘,温。归肝、肾经,补血,活血,通络。用于月经不调,血虚萎黄,麻木瘫痪,风湿痹痛活血舒筋;养血调经,《本草纲目拾遗》载其能医手足麻木;肢体瘫痪;风湿痹痛;妇女有经不调;痛经。
百部性味甘苦,微温。《别录》:微温。《药性论》:味甘,无毒。《日华子本草》:味苦,无毒。性味甘、苦,微温。归肺经。功能主治】润肺下气止咳,杀虫。用于新久咳嗽,肺痨咳嗽,百日咳;外用于头虱,体虱,蛲虫病,阴部骚痒。
冰片用于疮疡肿痛,溃后不敛。本品亦有清热解毒、防腐生肌作用。通诸窍,散郁火,去翳明目,消肿止痛。治中风口噤,热病神昏,惊痫痰迷,气闭耳聋,喉痹,口疮,中耳炎,痈肿,痔疮,目亦翳膜,蛲虫病。
乌梅,酸涩而温,似有类于木瓜,但此入肺则收,入肠则涩,入筋与骨则软,入虫则伏,入于死肌、恶肉、恶痣则除,虫得酸则伏,虫伏则痒止。是杀虫止痒的良药。
马齿苋酸,寒。归肝、大肠经。适用于痢疾、清热解毒,凉血止血。用于热毒血痢,痈肿疔疮,真菌性皮肤病,丹毒,蛇虫咬伤,便血,痔血,崩漏下血。《开宝重定新本草》:“马齿苋,服之长年不白。”《本草经疏》:“长年不白,总言其凉血益血,疾去身轻之功耳。”
地肤子:性寒,味辛、苦。功能主治清热利湿,祛风止痒。用于小便涩痛、阴痒带下、风疹、湿疹、皮肤瘙痒。《别录》:″去皮肤中热气,散恶疮,疝瘕,强阴,使人润泽。″《滇南本草》:″利膀胱小便积热,洗皮肤之风,疗妇人诸经客热,清利胎热,湿热带下。
红藤味苦性平,入大肠经。功用清热解毒、活血散瘀、祛风杀虫。用 于肠痈腹痛、风湿痹痛、跌打伤痛,妇女痛经,赤痢,血淋,疳积虫痛等症
《叶天士女科》治妇女带下,主张“升阳益阴则清浊自分,补脾养胃则湿热自除,尤当断厚味,补元阳,而带下可止矣。”故治疗中,本发明任宗古而不泥古,内服与外治、整体与局部相结合,以补肝肾为本,兼用清热解毒、祛风止痒外洗为标内外合用,从而收到较好的治疗效果。一味寻求外部解决而不从机体内部调理是不可取的,所以本中药组合包括内服养血调经,补肾滋阴的内服药物。本中药组合中内服药方中当归,制首乌,黄芪,大枣具以补血益气之功效,却补而不燥,非常适合女性调经养血;桑葚,鸡血藤是治疗妇女带下,痛经血淤之良药;有助于活血化淤;旱莲草、菟丝子强肝补肾,覆盆子都益胃补肾、固肾益精非常适合女性滋阴补血。内服药物旨在从内而外调理女性身体,达到祛病强体的目的。
白术味苦、甘,温。归脾、胃经。主治健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。《药性论》载其:君,味甘,辛,无毒。能主大风痹,多年气痢,心腹胀痛,破消宿食,开胃,去痰涎,除寒热,止下泄。主面光悦,驻颜,去黑。治水肿胀满,吐呕逆,腹内冷痛,吐泻不住,及胃气虚冷痢。
山药味甘、性平,入肺、脾、肾经;不燥不腻,有健脾补肺、益胃补肾、固肾益精、聪耳明目、助五脏、强筋骨、长志安神、延年益寿的功效;主治脾胃虚弱、倦怠无力、食欲不振、久泄久痢、肺气虚燥、痰喘咳嗽、肾气亏耗、腰膝酸软、下肢痿弱、消渴尿频、遗精早泄、带下白浊、皮肤赤肿、肥胖等病症。《本草纲目》概括五大功用“益肾气,健脾胃,止泄痢,化痰涎,润皮”。山药煮粥或者用冰糖煨熟后服用,对身体差、肠炎、肾亏等慢性病均有疗效。补益脾胃:治疗脾胃虚弱、泄泻、体倦、食少、虚汗。益肺滋肾:本品不寒不燥,味甘质润,可治疗肺肾虚损的消渴、遗精、带下等病证。被誉为神仙药。
当归,其味甘而重,故专能补血,其气轻而辛,故又能行血,补中有动,行中有补,诚血中之气药,亦血中之圣药。大约佐之以补则补,故能养营养血,补气生精,安五脏,强形体,益神志,凡有形虚损之病,无所不宜。佐之以攻则通,故能祛痛通便,利筋骨,治拘挛、瘫痪、燥、涩等 证。营虚而表不解者,佐以柴、葛、麻、桂等剂,大能散表卫热,而表不敛者,佐以大黄之类,又能固表。惟其气辛而动,故欲其静者当避之,性滑善行,大便不固者当避之。凡阴中火盛者,当归能动血,亦非所宜,阴中阳虚者,当归能养血,乃不可少。
鸡血藤性苦、甘,温。归肝、肾经,补血,活血,通络。用于月经不调,血虚萎黄,麻木瘫痪,风湿痹痛活血舒筋;养血调经,《本草纲目拾遗》载其能医手足麻木;肢体瘫痪;风湿痹痛;妇女有经不调;痛经。花椒,鸡血藤内服也是治疗妇科血淤不散,痛经的良药。
大枣富含蛋白质、脂肪、糖类、胡萝卜素、B族维生素、维生素C、维生素P以及钙、磷、铁和环磷酸腺苷等营养成分中医中药理论认为,红枣具有补虚益气、养血安神、健脾和胃等作用,是脾胃虚弱、气血不足、倦怠无力、失眠多梦等患者良好的保健营养品果。大枣补中益气,养血安神。用于脾虚食少,乏力便溏,妇人脏躁。能行气,活血,调经。用于月经不调,红崩,白带,是补血佳品。
黄芪以补虚为主,能补气固表,利尿托毒,排脓,敛疮生肌。用于气血不足、疮疡内陷、脓成不溃或久溃不敛者。黄芪具有很好的托毒生肌的功能,即久不愈合的脓肿化脓生肌。现代医学研究表明,黄芪内含而多种抗菌有效成分,而且能增强机体的免疫功能,因此还能用于预防某些传染病的发生。《本草逢原》载:“黄芪能补五脏诸虚,治脉弦自汗,泻阴火,去肺热,无汗则发,有汗则止。”是增进抵抗力和防御疾病的良药。
熟地黄甘,微温。归肝、肾经。功能主治滋阴补血,益精填髓。用于肝肾阴虚,腰膝酸软,骨蒸潮热,盗汗遗精,内热消渴,血虚萎黄,心悸怔忡,月经不调,崩漏下血,眩晕,耳鸣,须发早白。
丹皮味苦,微寒,能清营分、血分实热,有凉血止血之功。治温病热入营血,迫血妄行。归肝经。功能主治清热凉血,散瘀止痛。用于温毒发斑,吐血衄血,目赤肿痛,肝郁胁痛,经闭痛经,症瘕腹痛,跌扑损伤,痈肿疮疡。丹皮清热凉血的作用较佳,既能清血分实热,又能治阴虚发热。《本经》载其:“主寒热,中风契从、痉、惊痫邪气,除坚症瘀血留舍肠胃,安五脏,疗痈疮。
黄芩有清热燥湿,凉血安胎,解毒功效。主治温热病、上呼吸道感染、 肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症。黄芩的临床应用抗菌比黄连还好,而且不产生抗药性。我们借助广谱抗菌作用强的特点,用在真菌培养杂菌感染特厉害,用黄芩提取液效果很好。《本草经疏》:黄芩,其性清肃,所以除邪:味苦所以燥湿;阴寒所以胜热,故主诸热。诸热者,邪热与遍热也,黄疸、肠僻、泄痢,皆湿热胜之病也,析其本,则诸病自瘳矣。苦寒能除湿热,所以小肠利而水自逐,源清则流洁也。血闭者,实热在血分,即热人血室,令人经闭不通,湿热解,则荣气清而自行也。恶疮疽蚀者,血热则留结,而为痈肿渍烂也:火疡者,火气伤血也,凉血除热,则自愈也。黄芩有抗变态反应及抗炎作用:黄芩所含黄芩甙与黄芩素能明显抑制致敏豚鼠离体小肠与离体气管对抗原所产生的过敏性收缩反应,对豚鼠与小鼠的被动全身性变态反应以及豚鼠被动性皮肤变态反应,黄芩甙与黄芩素亦有抑制作用。黄芩有解热作用,多数试验证明,黄芩的有效成份黄芩甙元有解热作用。黄芩有解毒作用,黄芩甙有明显的解毒作用,这可能是由于在β-葡萄糖醛酸甙酶的作用下,黄芩甙分解出葡萄糖醛酸,并与多种毒物结合所致。黄芩甙10毫克能提高士的宁的LD50达2.5倍,并且使四氯化碳中毒小鼠的肝糖原含量增多。
中药何首乌有生首乌与制首乌之分,直接切片入药为生首乌,用黑豆煮汁拌蒸后晒干入药为制首乌。二者的功用有所不同:生首乌功能解毒、消痈、润肠通便,常用于治疗瘰疬疮痈、风疹瘙痒、肠燥便秘;制首乌功能补肝肾、益精血、乌须发、强筋骨,用于血虚萎黄、眩晕耳鸣、须发早白、腰膝酸软、肢体麻木、崩漏带下、久疟体虚等。本发明所采用的制首乌是补肾益肾的佳品。
墨旱莲,别名旱莲草,黑墨草,水旱莲等,性味甘酸,凉血,止血,补肾,益阴。治吐血,咳血,衄血,尿血,便血,血痢,刀伤出血,须发早白,白喉,淋浊、带下,阴部湿痒。《本草纲目》说它能“乌髭发,益肾阴。”《本草正义》认为旱莲草“入肾补阴而生长毛发。”
菟丝子甘辛平,入肝、肾经。补肾益精,养肝明目,安胎。用于肝肾亏虚,腰膝酸痛,阳痿遗精,尿频遗尿,两目昏暗,胎动不安等症。功能滋补肝肾,固精缩尿,安胎,明目,止泻。用于阳痿遗精、尿有余沥、遗 尿尿频、腰膝酸软、目昏耳鸣、肾虚胎漏、胎动不安、脾肾虚泻。
泽泻中医理论认为其性寒,具有利水渗湿的功效。现代医学研究,泽泻可降低血清总胆固醇及三酰甘油含量,减缓动脉粥样硬化形成;泽泻及其制剂还用于治疗内耳眩晕症、血脂异常、遗精、脂肪肝及糖尿病等。《本草正义》:泽泻,最善渗泄水道,专能通行小便。《本经》气味虽曰甘寒,兼以其生长水泽,因谓之寒,其实轻淡无味,甘于何有?此药功用,惟在淡则能通,《本经》称其治风寒湿痹,亦以轻能入络,淡能导湿耳,云治风寒,殊非其任。其能治乳难者,当以娩后无乳者言,此能通络渗泄,则可下乳汁,非产乳百病之通用品。其兼能滑痰化饮者,痰饮亦积水停湿为病,惟其滑利,故可消痰。总之,渗泄滑泻之药,必无补养之理。《本经》养五脏,益气力云云,已属溢美太过,而甄权竟谓可治肾虚精自出,大明且谓补女人血海,令人有子,洁古亦谓入肾经,去旧水,养新水。皆非药理之真。《本经》:主风寒湿痹,乳难,消水,养五脏,益气力,肥健。
覆盆子植物可入药,有多种药物价值,其果实有补肾壮阳的作用。覆盆子油属于不饱和脂肪酸,可促进前列腺分泌苛尔蒙。功效:补肝益肾,固精缩尿,明目。以大鼠、兔的阴道涂片及内膜切片作观察指标,覆盆子似有雌激素样作用。抑菌作用100%煎剂用平板打洞法,对葡萄球菌有抑制作用,对霍乱弧菌也有抑制作用。雌激素样作用大鼠、兔的阴道涂片及内膜切片等指标表明,覆盆子似有雌激素样作用。
桑葚补血滋阴,生津润燥。用于眩晕耳鸣,心悸失眠,须发早白,津伤口渴,内热消渴,血虚便秘。补肝,益肾,熄风,滋液。治肝肾阴亏,消渴,便秘,目暗,耳鸣,瘰疬,关节不利。桑葚有改善皮肤(包括头皮)血液供应,营养肌肤,使皮肤白嫩及乌发等作用,并能延缓衰老。桑葚是中老年人健体美颜、抗衰老的佳果与良药。常食桑椹可以明目,缓解眼睛疲劳干涩的症状。桑葚具有免疫促进作用。桑葚对脾脏有增重作用,对溶血性反应有增强作用,可防止人体动脉硬化、骨骼关节硬化,促进新陈代谢。它可以促进血红细胞的生长,防止白细胞减少,并对治疗糖尿病、贫血、高血压、高血脂、冠心病、神经衰弱等病症具有辅助功效。桑椹具有生津止渴、促进消化、帮助排便等作用,适量食用能促进胃液分泌,刺激肠蠕动及解除燥热。祖国医学认为,桑葚性味甘寒,具有补肝益肾、生津 润肠、乌发明目等功效。
本中药组合内外兼治,以内养外,标本兼治,内服外用药物两者相互促进,提高妇女自身免疫力,并对人体不产生任何副作用,安全有效,能达到祛病强体的目的。
本发明内服蜜炼丸剂的制备方法为:取制首乌1000g,当归1000g,白术1000g,山药1000g,黄芪1000g,大枣1000g,菟丝子1000g,鸡血藤1000g,桑葚1000g,泽泻1000g,旱莲草1000g,覆盆子1000g,熟地黄1000g份,黄芩1000g,丹皮1000g;先将所述内服原料药粉碎成粗粉,再进一步粉碎,过100目~120目筛,使能通过筛的细粉量为30%,收集通过筛的细粉得细粉a;再将不能通过120目筛的粗粉投入多功能提取罐提取两次,第一次加10倍量水煎煮1小时,第二次加8倍量水煎煮1小时,合并两次煎液,过滤得滤液;加热浓缩至糊状,放入烘箱80℃烘干后冷却,研磨成细粉b,将a与b混合后调入蜂蜜制成蜜炼丸剂。
本发明外用坐浴剂的制备方法包括:取黄柏1500g,苦参1500g,蛇床子1500g,青黛1500g,艾叶1500g,百部1500g,红藤1500g,鸡血藤1500g,花椒1500g,乌梅1500g,地肤子1500g,马齿苋1500g,选购配方中的药材,除杂质,除冰片外,其余药材加水浸泡30分钟至1小时,加热煮沸40分钟,过滤,滤液备用。滤渣加水,第二次加热,煮沸30分钟,再过滤,滤液备用;滤渣再加水,第三次加热煮沸30分钟,过滤。将三次滤液合在一起,加热浓缩至糊状,放入烘箱,控制在90℃,烘干后冷却,与冰片1500g混在一起研末成细粉状。以每袋2g分袋入塑料袋中,即成坐浴剂。药剂用法:治疗时,取本品2g加入温开水2000毫升坐浴,使药液浸泡病变位20至30分钟,每日一次。每5天一疗程。
本发明治疗滴虫性阴道炎的中药组合,外用药剂可以单独使用,作为妇科洗液,预防治疗各种阴道炎的妇科用药。
本发明外用栓剂的制备方法:则取基质加热融化,温度50℃~60℃,加入本发明散剂制得的细粉,水浴搅拌均匀,混合成粘稠的液体,灌注在塑料定型管内,插入棉栓,冷却定型制成类似子弹头状栓剂。一般所用基质可为:半合成脂肪酸甘油酯、羊毛脂、聚乙二醇,药细粉与基质的配比为1∶2~1∶4,优选为1∶3,或采用泊洛沙姆poloxamer作为基质,其已 被广泛用作栓剂的亲水性基质,具有以下优点:比其他基质的溶解度柔和、快速,载药量也较高。为了使用方便,棉栓可选用尾部带有棉线的棉栓。所述栓剂的具体用法如下:将本发明药物栓剂除去塑料外壳,取出药栓,拉出尾部棉线,将药栓纳入阴道深部,棉线留在体外,每晚1粒,次日晨起拉出棉栓,连续用药5天为一疗程。
本发明内服散剂制备方法:取制首乌1000g,当归1000g,白术1000g,山药1000g,黄芪1000g,大枣1000g,菟丝子1000g,鸡血藤1000g,桑葚1000g,泽泻1000g,旱莲草1000g,覆盆子1000g,熟地黄1000g份,黄芩1000g,丹皮1000g;将所述原料药混合,切碎,浸泡将浸泡好的原料药加重量份数比为5~8倍量水加热回流提取2次,每次1~2小时,将2次提取液合并静置;将上述水提取过的药渣加5~8倍量60~70%乙醇加热回流提取2次,每次1~2小时,将2次提取液合并静置。将上述两种提取液合并,减压浓缩相对密度为1.35(80℃)的滤液,回收乙醇,将所得滤液调整比重到1.06,减压得浸膏,用Co60灭菌,辐照剂量8k,放入烘箱内干燥成散剂。
本发明外用散剂的制备方法为:黄柏1500g,苦参1500g,蛇床子1500g,青黛1500g,艾叶1500g,百部1500g,红藤1500g,鸡血藤1500g,花椒1500g,乌梅1500g,地肤子1500g,马齿苋1500g,将所述原料药混合,切碎,浸泡将浸泡好的原料药加重量份数比为5~8倍量水加热回流提取2次,每次1~2小时,将2次提取液合并静置;将上述水提取过的药渣加5~8倍量60~70%乙醇加热回流提取2次,每次1~2小时,将2次提取液合并静置。将上述两种提取液合并,减压浓缩相对密度为1.35(80℃)的滤液,回收乙醇,将所得滤液调整比重到1.06,减压得浸膏,用Co60灭菌,辐照剂量8k,放入烘箱内加粉碎的冰片1500g干燥成散剂。
毒理学试验:
试验例1:本发明急性毒性试验
一、试验材料:
动物:昆明种小鼠,体重21-24g,雌雄各半,山东大学生物试验室育种。药物:本发明片剂,含0.0365g生药/片
二、方法:
1、LD50计算:采用改良寇氏法,将小鼠随机分成5组,每组10只,雌雄各半,将片剂加蒸馏水溶解,配成最大浓度,按小鼠最大允许容量给药,所给剂量按生药量依次为18,14.4,11.5,9.2,7.4(g.kg-1),在动物禁食(不禁水)18小时后,一日内分两次给药(间隔半小时),每次0.5ml,观察动物死亡情况。
2、最大耐受剂量测定(MTD值):取小鼠20只,雌雄各10只。将片剂加蒸馏水溶解,配成最高浓度,按动物的最大耐受量,以注射灌喂器能抽动为准。在动物禁食(不禁水)18小时后,一日内分两次给药(间隔半小时),每次0.5ml(每ml含生药0.36g),总药量为18g生药/kg.d,相当临床成人50Kg体重用量的300倍。给药后连续观察7天。
三、试验结果:
在LD50计算中当用最大允许浓度和最大允许容量给予小鼠时(18g/Kg.d),未见小鼠死亡,即未测出LD50,只可求最大耐受剂量,在7天观察期中,动物其食欲、活动、毛色、精神状态等皆正常,发育正常,未见有死亡。即选用相当于临床剂量的300倍药量,并无不良反应发生,
表明急性毒性极小,MTD>18g/Kg.d。
实验例2:长期毒性实验资料
1、实验方法
将豚鼠随机份成4组,每组15只。在豚鼠背部脊柱两侧将脱毛剂均匀涂上,使其脱毛范围约40平方厘米。洗净脱毛剂,观察24小时后每组豚鼠分别涂本发明内服中药制剂蜜炼丸剂0.2、0.4和0.8ml,分别含生药92、184和368mg,另一组涂溶媒0.8ml每日二次,连续30天,观察豚鼠的一般情况,实验结束后处死动物进行血液学、血液生化及病理学检查。
2、结果
上述三组用药豚鼠躯干去毛区,未见局部皮肤有水肿、充血、红斑、出血点及溃疡。用药组与对照组动物毛发色泽、摄食、四肢活动等对照组无明显差异,血液生化检查,用药组与对照组均在正常范围。病理组织学检查,实验各组心、肝、肾及局部皮肤均未见明显病变。提示,本发明中药制剂长期用药对局部皮肤及全身重要脏器均未见明显的毒性作用。试验结果表明:本发明中药制剂实验安全。该药对乙型链球菌、金黄色葡萄球 菌、大肠杆菌的最小抑制浓度为1∶150,淋球菌为1∶150,白色念珠菌为1∶300,对阴道滴虫1∶20稀释度时的杀灭时间为5分钟,1∶50时为10分钟,1∶100时为20分钟,1∶200时为40分钟,1∶400时为8小时。
实验例3:累计毒性实验:
本发明中药制剂内服蜜炼丸剂剂对小鼠按7.69、19.18和43.21g生药/kg连续用药15周(1.0ml/100g体重,每天2次)及停药3周后,结果表明:本发明中药制剂对大鼠的毛发、行为、大小便、体重、脏器重量、血象、肝肾功能、血糖、血脂等指标均无明显影响,脏器肉眼没有发现异样变化和组织学检查结果表明,用药15周及停药3周后,大鼠各脏器均无明显改变。说明本发明中药制剂内服胶囊剂对大鼠长期用药后毒性小,停药后也没有异样反应,应用安全。
实验例4:皮肤刺激性试验
取家兔剃毛,对该外用药物散剂进行诱导和激发接触试验,在24小时和48小时后观察试验家兔,均不见皮肤有红斑及水肿等现象,与阴性对照组无差异。结果表明,该制剂对皮肤反应强度近于零,即无皮肤变态反应。对白鼠阴道和破损皮肤进行刺激性试验,未见有刺激性反应和其它不良。对滤过性病毒有抑制和杀灭作用反应。毒性试验证明,该药未有毒性作用和不良反应,临床应用安全可靠。
药效学试验
受试药物:本发明外用散剂,可加水制成浓度不一的洗液。阳性药物为洁尔阴洗液。受试动物:ICR品系小白鼠,SD品系大鼠、豚鼠,雌雄各半或单雄性,由山东大学生物系提供,体重:小鼠18~22g、大白鼠220~300g、豚鼠340~420g。动物饲养条件:实验室空调控温,室温25~28℃,相对湿度45%~75%。(一)体外抗菌试验
培养基:肉汤培养基、肉汤琼脂培养基、血平板、巧克力平板;菌种:选用大肠杆菌、绿脓杆菌、金黄色葡萄球菌、白色念珠菌、变形杆菌、淋球菌、丙型链球菌、卡他球菌等菌种;方法:稀释法,将本发明洗剂I号和II号0.1g/mL用肉汤自1∶5至1∶160作倍比稀释,每管含药液2ml,第9管为无药对照,每管中加入稀释菌液1滴,37℃孵育18h,肉眼观察结果,含药最低浓度尚呈明显不混浊管为该药的最小抑菌浓度(MIC)。淋球 菌在肉汤中生长不良,改用巧克力平板稀释法测最小抑菌浓度。如下表:
| 菌株 | 最低抑菌浓度(MIC)(mg/ml) |
| 白色念珠菌 | 4.135 |
| 淋球菌 | 11.8 |
| 丙型链球菌 | 27 |
| 绿脓杆菌 | 5.95 |
| 大肠杆菌 | 51 |
| 卡他球菌 | 23 |
| 金黄色葡萄球菌 | 6.18 |
结果表明本发明洗剂均对大肠杆菌、绿脓杆菌、金黄色葡萄球菌、白色念珠菌、变形杆菌、卡他球菌、丙型链球菌的最小抑菌浓度为5mg/ml,淋球菌为10mg/ml。对大肠杆菌、绿脓杆菌、金黄色葡萄球菌、白色念珠菌、变形杆菌、卡他球菌、丙型链球菌、淋球菌均有明显的抑菌作用。
(二)抗阴道滴虫试验
将培养基按比例配制,分装4瓶,分别装入等容生理盐水(空白对照组)、0.5%、1%、2%的本发明洗剂,分装于无菌试验管内,每管约2ml。取新鲜的镜检证明滴虫阳性的标本0.2ml,加入上述7支不同成分的试管内,立即送入37℃温箱置24~48小时,取出后观察到液体混浊,无膜状物、极小沉淀,然后用无菌的长吸管吸取每根试管的上、中、下层观察结果。结果表明本发明对滴虫有很强的杀灭作用。
(三)抗炎作用试验
对蛋清所致大白鼠足跖肿胀的抑制作用:选用实验用大鼠,220~300g,雌雄各半,10只/组,左足踝皮下注射100%鸡蛋清液0.03ml/只致炎。1h、2h、4h、6h后各测量一次关节周长。求出各时间两足关节周长差为肿胀度,合并结果,进行各组间炎症抑制率的比较。如下表:
结果表明本发明本发明散剂洗液对大鼠足跖肿胀有非常显著的抑制作用。综上结果表明,本发明洗剂有明显的抗炎作用。
(五)镇痛作用试验(热板法测痛)
选用雌性小白鼠,18~22g,热板痛反应匣温度控制在55±0.5℃,以小白鼠后足作为痛反应指标,给药前先每隔5分钟测一次痛阈,共测两次,取均数作基础痛阈。给予小鼠本发明散剂洗液分别局部涂0.05ml每只,15ml一次,共4次,末次给药后1小时、2小时、3小时各测一次痛阈,比较各组间差异,结果表明本发明洗剂有明显提高痛阈作用。
注:药组与对照组比较*P<0.05,**P<0.01。从表3可知,本药各组与空白对照组比较均有非常显著性差异(P<0.01或P<0.05)。
通过上述药效学试验,证实了本发明洗剂对大肠杆菌、绿脓杆菌、金黄色葡萄球菌、白色念珠菌、变形杆菌、卡他球菌、丙型链球菌、淋球菌 均有明显的抑菌作用;对滴虫有杀灭作用;局部给药对蛋清性大鼠足跖肿胀有抗炎消肿作用,并能明显的提高致痒阈值,还有明显提高痛阈作用,为本发明洗剂的有效性提供了可靠的依据。
临床资料
1资料与方法
1.1一般资料
选择我院门诊2008年5月至2010年5月滴虫性阴道炎患者120例;年龄18~56岁,均有性生活史。
1.2诊断标准症状
有接触性出血、外阴瘙痒、灼痛或伴有尿频、尿急、尿痛等尿道刺激症状或伴有局部刺激症状。妇科检查:宫颈及阴道黏膜充血,分泌物异常。阴道分泌物呈黄色泡沫状。实验室检查:滴虫性阴道炎,在阴道分泌物中显微镜下找到滴虫;阴道清洁度在II度以上。阴道pH值5.5~6。
1.3治疗方法
基本方:内服:制首乌10g,当归15g,白术10g,山药10g,黄芪10g,大枣10g,菟丝子10g,鸡血藤10g,桑葚15g,泽泻10g,旱莲草10g,覆盆子10g,熟地黄10g,黄芩10g,丹皮10g;制成丸剂,每日三次,一次一丸。
外用:黄柏10g,苦参15g,蛇床子10g,青黛10g,艾叶10g,百部15g,红藤10g,鸡血藤10g,花椒15g,乌梅10g,地肤子10g,冰片10g,马齿苋10g。上药煎制成250mL药液,用一次性导尿管套在20mL注射器上,冲洗阴道,每日1次,7d为1疗程,连续治疗1个疗程,月经期后,再行下1个疗程。分别于治疗前、治疗后、3次月经后进行妇科检查、分泌物常规检查。
2结果
2.1疗效标准痊愈
痊愈:经2个疗程治疗症状、体征消失,镜检未见滴虫,3次月经后复查阴道分泌物滴虫为阴性;有效:经2个疗程治疗症状、体征减轻,3次月经后复查有1次阴道分泌物检查滴虫为阳性;无效:治疗后症状、体征无变化。
2.2治疗结果
120例治疗2个疗程后,治愈98例,占81.7%;有效17例,占14.2%;无效 5例,占4.1%;总有效率95.8%。
具体实施例1佘某,25岁,已婚。以“外阴阴道瘙痒、灼热1周,加重1d”为主诉就诊。平时带下稠粘而黄,有恶臭。妇科检查症状:阴道分泌物增多,呈黄绿色泡沫状,有臭味而质稀。外阴瘙痒、灼热,阴道黏膜及宫颈呈“草莓样”外观。诊断:滴虫性阴道炎。使用如下配方:
内服药物为:制首乌10g,当归15g,白术10g,山药10g,黄芪10g,大枣10g,菟丝子10g,鸡血藤15g,桑葚10g,泽泻10g,旱莲草10g,覆盆子10g,熟地黄10g,黄芩15g,丹皮10g;
外用药物为:黄柏15g,苦参15g,蛇床子10g,青黛15g,艾叶10g,百部15g,红藤10g,鸡血藤15g,花椒15g,乌梅10g,地肤子10g,冰片10g,马齿苋10g。5d为1疗程。第1疗程结束后,症状完全消失,白带转为稀薄,臭味消除,瘙痒缓解,巩固2疗程后临床治愈,随访3个月无复发。
具体实施例2:方某,31岁,自述经前三天开始及经期小腹疼痛拒按,阵发下腹绞痛,腹部灼热,腰胀痛,时有恶心呕吐,出冷汗、手足发凉,经色黯红,质稠有块,平时带下稠粘而黄,有恶臭。妇科检查症状:阴道分泌物增多,呈黄绿色泡沫状,有臭味而质稀。外阴瘙痒、灼热,阴道黏膜及宫颈呈“草莓样”外观,后穹隆有大量的黄绿色泡沫状分泌物,悬滴显微镜检查可见游动的毛滴虫及大量脓细胞。诊断滴虫性阴道炎,使用如下配方治疗:
内服药物为:制首乌10g,当归15g,白术15g,山药10g,黄芪10g,大枣10g,菟丝子10g,鸡血藤15g,桑葚10g,泽泻15g,旱莲草10g,覆盆子10g,熟地黄10g,黄芩15g,丹皮15g;
外用药物为:黄柏15g,苦参10g,蛇床子15g,青黛10g,艾叶10g,百部15g,红藤10g,鸡血藤10g,花椒10g,乌梅15g,地肤子10g,冰片10g,马齿苋10g。5d为一疗程。第1疗程结束后,症状消失,白带正常,异味消失,瘙痒停止。巩固一疗程后治愈,随访6个月无复发。
具体实施例3:李某,女,24岁,瘙痒,恶臭,体检有接触性出血、外阴瘙痒、灼痛或伴有尿频、尿急、尿痛等尿道刺激症状或伴有局部刺激症状。妇科检查:宫颈及阴道黏膜充血,白带增多。阴道分泌物呈黄色泡沫状。实验室检查:滴虫性阴道炎,在阴道分泌物中显微镜下找到滴虫;阴道清洁度在II度以 上。内服药物为:制首乌10g,当归15g,白术15g,山药10g,黄芪10g,大枣10g,菟丝子10g,鸡血藤15g,桑葚10g,泽泻15g,旱莲草10g,覆盆子10g,熟地黄10g,黄芩15g,丹皮15g;
外用药物为:黄柏15g,苦参10g,蛇床子15g,青黛10g,艾叶10g,百部15g,红藤10g,鸡血藤10g,花椒10g,乌梅15g,地肤子10g,冰片10g,马齿苋10g。经2个疗程治疗症状、体征消失,镜检未见滴虫,3次月经后复查阴道分泌物滴虫为阴性;彻底痊愈。
Claims (6)
1.一种治疗滴虫性阴道炎的中药组合物,其特征在于,由内服药物和外用药物组成,所述内服药物中各种原料药的重量份数比为:制首乌10~20份,当归10~20份,白术10~20份,山药10~20份,黄芪10~20份,大枣10~20份,菟丝子10~20份,鸡血藤10~20份,桑葚10~20份,泽泻10~20份,旱莲草10~20份,覆盆子10~20份,熟地黄10~20份,黄芩10~20份,丹皮10~20份;
所述外用药物中,各种原料药的重量份数比为:黄柏10~30份,苦参10~30份,蛇床子10~30份,青黛10~30份,艾叶10~30份,百部10~30份,红藤10~30份,鸡血藤10~30份,花椒10~30份,乌梅10~30份,地肤子10~30份,冰片10~30份,马齿苋10~30份。
2.根据权利要求1所述治疗滴虫性阴道炎的中药组合物,其特征在于,所述内服药物中各种原料药的重量份数比为:制首乌10~20份,当归10~20份,白术10~20份,山药10~20份,黄芪10~20份,大枣10~20份,菟丝子10~20份,鸡血藤10~15份,桑葚10~15份,泽泻10~15份,旱莲草10~15份,覆盆子10~15份,熟地黄10~15份,黄芩10~15份,丹皮10~15份;
所述外用药物中,各种原料药的重量份数比为:黄柏10~30份,苦参10~30份,蛇床子10~30份,青黛10~30份,艾叶10~30份,百部10~15份,红藤10~15份,鸡血藤10~15份,花椒10~15份,乌梅10~15份,地肤子10~15份,冰片10~15份,马齿苋10~15份。
3.根据权利要求1所述治疗滴虫性阴道炎的中药组合物,其特征在于,所述内服药物中各种原料药的重量份数比为:制首乌10~15份,当归10~15份,白术10~15份,山药10~15份,黄芪10~15份,大枣10~15份,菟丝子10~15份,鸡血藤10~20份,桑葚10~20份,泽泻10~20份,旱莲草10~20份,覆盆子10~20份,熟地黄10~20份,黄芩10~20份,丹皮10~20份;
所述外用药物中,各种原料药的重量份数比为:黄柏10~15份,苦参10~15份,蛇床子10~15份,青黛10~15份,艾叶10~15份,百部10~30份,红藤10~30份,鸡血藤10~30份,花椒10~30份,乌梅10~30份,地肤子10~30份,冰片10~30份,马齿苋10~30份。
4.一种如权利要求1~3中任一项所述治疗滴虫性阴道炎的中药组合物的制备方法,其特征在于,所述内服药物的剂型为蜜炼丸剂的制备方法包括:先将所述内服原料药粉碎成粗粉,再进一步粉碎,过100目~120目筛,使能通过筛的细粉量为30%,收集通过筛的细粉得细粉a;再将不能通过120目筛的粗粉投入多功能提取罐提取两次,第一次加5-10倍量水煎煮1-2小时,第二次加4-8倍量水煎煮1-2小时,合并两次煎液,过滤得滤液;加热浓缩至糊状,放入烘箱80℃烘干后冷却,研磨成细粉b,将a与b混合后调入蜂蜜制成蜜炼丸剂。
5.一种如权利要求1~3中任一项所述治疗滴虫性阴道炎的中药组合物的制备方法,其特征在于,所述外用药物的剂型为栓剂的制备方法包括:将所述原料药除冰片外,其余加水浸泡30分钟至1小时,加热煮沸30~40分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30~40分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸30~40分钟,过滤;将三次滤液合在一起,加热浓缩至膏状,加入研碎的冰片混在一起;选取基质50℃~60℃加热融化,加入上述得到的药膏冷却定型制成类弹头状栓剂。
6.根据权利要求5所述制备方法,其特征在于,所述基质选自:半合成脂肪酸甘油酯、泊洛沙姆、聚乙二醇、羊毛脂中的一种或多种。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100918471A CN102178814B (zh) | 2011-04-13 | 2011-04-13 | 一种治疗滴虫性阴道炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100918471A CN102178814B (zh) | 2011-04-13 | 2011-04-13 | 一种治疗滴虫性阴道炎的中药组合物及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102178814A CN102178814A (zh) | 2011-09-14 |
| CN102178814B true CN102178814B (zh) | 2012-11-07 |
Family
ID=44565220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011100918471A Expired - Fee Related CN102178814B (zh) | 2011-04-13 | 2011-04-13 | 一种治疗滴虫性阴道炎的中药组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102178814B (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102743595B (zh) * | 2012-06-17 | 2013-11-13 | 谷书华 | 一种治疗肾阴虚型滴虫性阴道炎的中药洗剂制备方法 |
| CN102743626B (zh) * | 2012-06-17 | 2013-09-04 | 伊金萍 | 一种治疗呕吐型滴虫性阴道炎的中药洗剂制备方法 |
| CN102743615B (zh) * | 2012-06-17 | 2013-12-11 | 任英霞 | 一种治疗发热型老年性阴道炎的中药洗剂制备方法 |
| CN102743591B (zh) * | 2012-06-17 | 2013-09-04 | 许银各 | 一种治疗疼痛型滴虫性阴道炎的中药洗剂制备方法 |
| CN102743724B (zh) * | 2012-06-17 | 2013-09-11 | 沈明臻 | 一种治疗脾虚型滴虫性阴道炎的中药洗剂制备方法 |
| CN103071096B (zh) * | 2013-01-30 | 2014-07-23 | 李秀娟 | 用于治疗老年性阴道炎的外用制剂及其制备方法 |
| CN105106763A (zh) * | 2015-10-08 | 2015-12-02 | 淄博齐鼎立专利信息咨询有限公司 | 一种治疗滴虫性阴道炎的中药栓剂 |
| KR102775140B1 (ko) * | 2024-12-04 | 2025-03-05 | (주)네오팜 | 노니, 대추, 크랜베리 및 비쑥 추출물을 포함하는 질염 또는 외음부염 개선, 예방 또는 치료용 조성물 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1188656A (zh) * | 1997-01-21 | 1998-07-29 | 何元森 | 益母草保健内裤及其制作方法 |
| CN1768812A (zh) * | 2005-10-24 | 2006-05-10 | 高欲林 | 一种用于除湿止痒的药物组合物及其制备方法和用途 |
| CN101062167A (zh) * | 2006-04-29 | 2007-10-31 | 杨文龙 | 一种用于治疗妇科疾病的中药组合物、制备方法及其用途 |
| CN101269192A (zh) * | 2007-03-20 | 2008-09-24 | 谢晓涛 | 一种治疗妇科炎症的中药组合物及其制剂 |
| CN101524499A (zh) * | 2009-04-10 | 2009-09-09 | 东方药林药业有限公司 | 一种妇科洗液及其制备方法 |
| CN101559188A (zh) * | 2009-05-18 | 2009-10-21 | 甘肃益尔药业股份有限公司 | 一种用于治疗阴道炎及手足癣的中药复方制剂及其制备方法 |
| CN101773630A (zh) * | 2010-03-16 | 2010-07-14 | 李克权 | 一种治疗妇科炎症的外用药 |
-
2011
- 2011-04-13 CN CN2011100918471A patent/CN102178814B/zh not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1188656A (zh) * | 1997-01-21 | 1998-07-29 | 何元森 | 益母草保健内裤及其制作方法 |
| CN1768812A (zh) * | 2005-10-24 | 2006-05-10 | 高欲林 | 一种用于除湿止痒的药物组合物及其制备方法和用途 |
| CN101062167A (zh) * | 2006-04-29 | 2007-10-31 | 杨文龙 | 一种用于治疗妇科疾病的中药组合物、制备方法及其用途 |
| CN101269192A (zh) * | 2007-03-20 | 2008-09-24 | 谢晓涛 | 一种治疗妇科炎症的中药组合物及其制剂 |
| CN101524499A (zh) * | 2009-04-10 | 2009-09-09 | 东方药林药业有限公司 | 一种妇科洗液及其制备方法 |
| CN101559188A (zh) * | 2009-05-18 | 2009-10-21 | 甘肃益尔药业股份有限公司 | 一种用于治疗阴道炎及手足癣的中药复方制剂及其制备方法 |
| CN101773630A (zh) * | 2010-03-16 | 2010-07-14 | 李克权 | 一种治疗妇科炎症的外用药 |
Non-Patent Citations (4)
| Title |
|---|
| 刘国应.妇科病的坐浴疗法.《农村百事通》.2007,(第19期),23. * |
| 吴忠兰.内外合治滴虫性阴道炎60例.《吉林中医药》.2007,第27卷(第01期),22. * |
| 张青等.中药内服外用治疗阴道炎46例.《陕西中医》.1999,第20卷(第05期),200. * |
| 范秀淑等.中药内服外洗治疗滴虫性阴道炎68例.《宁夏医学杂志》.2001,第23卷(第03期),183. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102178814A (zh) | 2011-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102145064B (zh) | 一种治疗老年性阴道炎的中药组合物及其制备方法 | |
| CN102145111B (zh) | 一种治疗霉菌性阴道炎的中药组合物及其制备方法 | |
| CN102048894B (zh) | 一种治疗烧伤的中药组合物及其制备方法 | |
| CN101804166B (zh) | 一种治疗小儿皮炎湿疹的中药组合物 | |
| CN102178814B (zh) | 一种治疗滴虫性阴道炎的中药组合物及其制备方法 | |
| CN103417904B (zh) | 一种治疗慢性唇炎的中药组合物及其制备方法 | |
| CN102178804B (zh) | 一种治疗肛周湿疹的中药组合物及其制备方法 | |
| CN101455738A (zh) | 一种治疗湿疹的中药组合物及其制备方法 | |
| CN103800772A (zh) | 一种防治阴道炎症的妇科外用洗液及其制备方法 | |
| CN102058715B (zh) | 一种治疗慢性前列腺炎的中药制剂及其制备方法 | |
| CN102000164B (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
| CN103721139A (zh) | 一种治疗龟头炎的中药组合物及其制备方法 | |
| CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
| CN105381352A (zh) | 一种治疗妇科炎症的外用中药洗液 | |
| CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
| CN101433655B (zh) | 一种治疗阴道炎的中药组合物 | |
| CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
| CN103041247B (zh) | 一种治疗阴道炎的中药栓剂及其制备方法 | |
| CN102846824B (zh) | 一种治疗寒湿血瘀阻络型糖尿病足的中药组合物及其制备方法 | |
| CN104274754A (zh) | 一种治疗小儿遗尿的中药组合物及其制备方法 | |
| CN104147538A (zh) | 一种治疗湿热毒盛型糖尿病足的中药制剂及其制备方法 | |
| CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
| CN102178781A (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
| CN104324350A (zh) | 一种用于慢性结肠炎的中药组合物及其制备方法 | |
| CN103721191A (zh) | 一种治疗妇女慢性盆腔炎的中药灌肠剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121107 Termination date: 20130413 |

